ConductScience.org, home

Paper17877503

Epidemiology of hepatocellular carcinoma in Japan.

Umemura T and 1 other. Hepatol Res, 2007. Cited by 69 papers, by iCite.

Cite this record

ConductScience Library. Epidemiology of hepatocellular carcinoma in Japan. Papers, record 17877503. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17877503

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Epidemiology of hepatocellular carcinoma in Japan.
PubMed
Journal
Hepatol Res
PubMed
Year
2007
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
69
iCite
Relative citation ratio, by iCite
1.93
iCite
Revised in PubMed
2020-09-30
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Umemura TTakeji
2Kiyosawa KKendo

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Cited by22

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 69 citations.

PMIDTitleJournalYearIn PapersSource
39273237Phase I-IV Drug Trials on Hepatocellular Carcinoma in Asian Populations: A Systematic Review of Ten Years of Studies.Int J Mol Sci2024https://conductscience.org/library/papers/39273237PubMed
26622825Clinicopathological characteristics of hepatitis B surface antigen-negative and hepatitis C antibody-negative hepatocellular carcinoma.Oncol Lett2015https://conductscience.org/library/papers/26622825PubMed
26475278Long-term prognosis after resection of cryptogenic hepatocellular carcinoma.BMC Surg2015https://conductscience.org/library/papers/26475278PubMed
26446004Efficacy of transcatheter arterial chemoembolization followed by sorafenib for intermediate/advanced hepatocellular carcinoma in patients in Japan: a retrospective analysis.Clin Drug Investig2015https://conductscience.org/library/papers/26446004PubMed
25252033Elevation of Serum Levels of Advanced Glycation End Products in Patients With Non-B or Non-C Hepatocellular Carcinoma.J Clin Lab Anal2015https://conductscience.org/library/papers/25252033PubMed
25165471Diagnostic Performance of Des-γ-carboxy Prothrombin for Hepatocellular Carcinoma: A Meta-Analysis.Gastroenterol Res Pract2014https://conductscience.org/library/papers/25165471PubMed
24510731Rare benign tumors of the liver: still rare?J Gastrointest Cancer2014https://conductscience.org/library/papers/24510731PubMed
24002762Surgical outcomes and clinical characteristics of elderly patients undergoing curative hepatectomy for hepatocellular carcinoma.J Gastrointest Surg2013https://conductscience.org/library/papers/24002762PubMed
23901350Comparison of clinical characteristics and survival after surgery in patients with non-B and non-C hepatocellular carcinoma and hepatitis virus-related hepatocellular carcinoma.J Cancer2013https://conductscience.org/library/papers/23901350PubMed
23404391Repeat hepatectomies for hepatic malignant lymphoma and hepatocellular carcinoma associated with chronic hepatitis C: report of a case.Surg Today2014https://conductscience.org/library/papers/23404391PubMed
23233864Epidemiological pattern of hepatitis B and hepatitis C as etiological agents for hepatocellular carcinoma in iran and worldwide.Hepat Mon2012https://conductscience.org/library/papers/23233864PubMed
23092095Immunoregulation of hepatitis B virus infection--rationale and clinical application.Nagoya J Med Sci2012https://conductscience.org/library/papers/23092095PubMed
22977473Prevalence of type 2 diabetes mellitus in Japanese patients with hepatocellular carcinoma.Exp Ther Med2011https://conductscience.org/library/papers/22977473PubMed
22651810Validation of the Japanese version of the EORTC hepatocellular carcinoma-specific quality of life questionnaire module (QLQ-HCC18).Health Qual Life Outcomes2012https://conductscience.org/library/papers/22651810PubMed
22563173Factors associated with the overall survival of elderly patients with hepatocellular carcinoma.World J Gastroenterol2012https://conductscience.org/library/papers/22563173PubMed
22320249Novel method to measure serum levels of des-gamma-carboxy prothrombin for hepatocellular carcinoma in patients taking warfarin: a preliminary report.Cancer Sci2012https://conductscience.org/library/papers/22320249PubMed
21484134Safety and tolerance of sorafenib in Japanese patients with advanced hepatocellular carcinoma.Hepatol Int2011https://conductscience.org/library/papers/21484134PubMed
21278701The incidence of hepatocellular carcinoma associated with hepatitis C infection decreased in Kyushu area.Med Sci Monit2011https://conductscience.org/library/papers/21278701PubMed
21128329Transarterial embolization ablation of hepatocellular carcinoma with a lipiodol-ethanol mixture.World J Gastroenterol2010https://conductscience.org/library/papers/21128329PubMed
19148802Epidemiology of hepatocellular carcinoma in Japan.J Gastroenterol2009https://conductscience.org/library/papers/19148802PubMed

See all 22 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/17877503

GET https://conductscience.org/api/papers/v1/17877503/cited_by?page=2